Drugplain

Montelukast 10 mg/1

Montelukast · TABLET, FILM COATED · Aphena Pharma Solutions - Tennessee, LLC

10 Recalls on RecordCurrently in Shortage
Plain English

Montelukast is a prescription tablet used to treat asthma and allergic rhinitis by reducing inflammation and constriction in the airways. It is taken by mouth and belongs to a class of medications called leukotriene receptor antagonists.

Key Facts

Brand Name
Montelukast
Generic Name
Montelukast
NDC Code (Product)
71610-563
Manufacturer
Aphena Pharma Solutions - Tennessee, LLC
Strength
10 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
ANDA202843
Marketing Start
02/11/2021

Recall History

10 Recalls on Record
Class III03/27/2023

Teva Pharmaceuticals USA Inc

Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

TerminatedVoluntary: Firm initiated
Class II02/07/2023

Accord Healthcare, Inc.

CGMP Deviations: recalling drug products following an FDA inspection.

TerminatedVoluntary: Firm initiated
Class II11/14/2014

Attix Pharmaceuticals

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

TerminatedVoluntary: Firm initiated
Class II03/23/2023

Preferred Pharmaceuticals, Inc.

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

OngoingVoluntary: Firm initiated
Class II04/06/2023

PD-Rx Pharmaceuticals, Inc.

CGMP deviations.

TerminatedVoluntary: Firm initiated
Class II08/20/2018

Hetero Labs Limited Unit V

Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.

TerminatedVoluntary: Firm initiated
Class III01/20/2020

Macleods Pharma Usa Inc

Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product

TerminatedVoluntary: Firm initiated
Class II10/13/2023

Dr. Reddy's Laboratories, Inc.

Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.

TerminatedVoluntary: Firm initiated
Class II03/13/2023

Direct Rx

cGMP deviations

TerminatedVoluntary: Firm initiated
Class I08/15/2018

Hetero Labs Limited Unit V

Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.

OngoingVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dyspnoea7,947 reports
asthma7,658 reports
drug ineffective6,118 reports
fatigue5,665 reports
headache4,934 reports
cough4,789 reports
nausea4,334 reports
off label use4,049 reports
pneumonia4,005 reports
pain3,744 reports

Frequently Asked Questions

What is Montelukast used for?

Montelukast is a prescription tablet used to treat asthma and allergic rhinitis by reducing inflammation and constriction in the airways. It is taken by mouth and belongs to a class of medications called leukotriene receptor antagonists.

Is Montelukast a controlled substance?

Montelukast is not classified as a controlled substance by the DEA.

What is the generic name for Montelukast?

The generic name for Montelukast is Montelukast. There are 7 other brand versions of Montelukast.

What is the NDC code for Montelukast 10 mg/1?

The NDC (National Drug Code) for Montelukast 10 mg/1 is 71610-563, listed by Aphena Pharma Solutions - Tennessee, LLC.